Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Myeloid-derived suppressor cells in cancer: therapeutic, predictive, and prognostic implications.

Seminars in oncology - 1 Apr 2014

Diaz-Montero C Marcela, Finke Jim, Montero Alberto J

Abstract excerpt

Immune evasion is a hallmark of cancer. While there are multiple different mechanisms that cancer cells employ, myeloid-derived suppressor cells (MDSCs) are one of the key drivers of tumor-mediated immune evasion. MDSCs begin as myeloid cells recruited to the tumor microenvironment, where they ar...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bone Marrow Cells
Share to Granulocytes
Share to Immune System

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunosuppression Therapy

Share to Immunotherapy

Share to Monocytes

Share to Myeloid Cells

Share to Tumor Escape

Source

Open in PubMed Open full text

Identifiers

PMID: 24787291
DOI: 10.1053/j.seminoncol.2014.02.003
PMCID: PMC4008844

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-24787291-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Myeloid-derived suppressor cells in cancer: therapeutic, predictive, and prognostic implications.PMID 24787291Read ↗

The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune Evasion.Semantic proximity Read ↗

Myeloid-Derived Suppressor Cells.Semantic proximity Read ↗

Complexity and challenges in defining myeloid-derived suppressor cellsSemantic proximity Read ↗

Complexity and challenges in defining myeloid-derived suppressor cellsSemantic proximity Read ↗

Phenotypes, accumulation, and functions of myeloid-derived suppressor cells and associated treatment strategies in cancer patients.Semantic proximity Read ↗

Myeloid-Derived Suppressor Cells: Immune-Suppressive Cells That Impair Antitumor Immunity and Are Sculpted by Their Environment.Semantic proximity Read ↗

Myeloid-Derived Suppressor Cells in Solid TumorsSemantic proximity Read ↗

Myeloid derived suppressor cells in physiological and pathological conditions: the good, the bad, and the ugly.Semantic proximity Read ↗

On the origin of myeloid-derived suppressor cells.Semantic proximity Read ↗

Evolution and Targeting of Myeloid Suppressor Cells in Cancer: A Translational PerspectiveSemantic proximity Read ↗

Myeloid‐derived suppressor cell heterogeneity in human cancersSemantic proximity Read ↗

Molecular Pathways: Myeloid Complicity in CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.